Cybin Inc N.CYBN

Too Funny...

[88guy88]

and they say the market is fair and not manipulated......what a joke!...LOL

way to paint the close there boys!

[superzoomer710]

I think it has the potential for value as well just having a hard time getting around the initial costs knowing full well drug development costs alone can be millions.  average phase 3 clinical trial is over 30,000,000   Based on the LS This thing has a mega burn rate to the tune of 2,282,000$ just in salary these guys are going to need an army of brilliance To accomplish the ambitious

[realitycheck00]

They just raised $45M and if you look at the biotech investors mentioned in the press release who invested in the last round they have over $400B AUM so im sure they will be fine to access the capital they need.  They have a more strategic investor base than Compass at this point. With these numbers only MindMed has slightly more cash in the till and they are working on multiple trials. 

[88guy88]

going on the Neo was a mistake....its more expensive to list on the TSX and its kinda funny how they could mis calculate how important the exchange is.....it they did not want to pay up for the TSX they certainly will not pay to list on Nasdaq.... the CSE would even have been better nobody looks at the Neo and they are suspicious when a company can't afford to go on the major established

[realitycheck00]

Agreed I think they are missing access to more investors who can access the NEO in the US but the NEO is not a cheaper solution and is a TIER 1 exchnage equivalent to the TSE and Nasdaq regarding compliance. Highly doubt it had anything to do with money and the NEO is working out fairly well for MinMed.  They need to get their OTC listing up and running to access US folks and hopefully their

[Jim1274]

Drysdale has stated from day 1 he plans on listing to the Nasdaq but they have to first meet the requirements without siting on too much cash for to long, he was very specific in saying he did not want too much cash on the books. Personally can't understand our volume levels, should be so much interest with the potential here..

[realitycheck00]

Its hard to access the NEO from US folks.  They need there OTC listing asap then US investors can come in.  Its also probably that seed round investors are selling which is good as a new floor can be created after. If you look at Field Trip that probably had much more press than Cybin they have much less volume daily.

[Jim1274]

Cybin is listed on the OTC...CLXPF

[realitycheck00]

Looks like grey market though.  They need to get up to OTCQB or OTCQX for a mass US appeal to buy the stock.  I dont even know if there is a proper bid / ask on the greys for most traders.

[Jim1274]

I'm not 100% sure, I know somebody mentioned OTC grey market but I'm in Canada so I trade the neo, I can see trades being made on the otc market though...my bank also has the otc ticker available, I just trade neo because of my location...